Top

Journal of Experimental & Clinical Cancer Research

Published in:

Open Access 01-12-2019 | Confusion | Correction

Correction to: Cell communication and signaling: how to turn bad language into positive one

Authors: Claudia Chiodoni, Maria Teresa Di Martino, Francesca Zazzeroni, Michele Caraglia, Massimo Donadelli, Stefania Meschini, Carlo Leonetti, Katia Scotlandi

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2019

Excerpt

Correction to: J Exp Clin Cancer Res …

Chiodoni, et al. Cell communication and signaling: how to turn bad language into positive one. J Exp Clin Cancer Res. 2019;38:128. https://doi.org/10.1186/s13046-019-1122-2.CrossRef

Title: Correction to: Cell communication and signaling: how to turn bad language into positive one
Authors: Claudia Chiodoni
Maria Teresa Di Martino
Francesca Zazzeroni
Michele Caraglia
Massimo Donadelli
Stefania Meschini
Carlo Leonetti
Katia Scotlandi
Publication date: 01-12-2019
Publisher: BioMed Central
Keyword: Confusion
Published in: Journal of Experimental & Clinical Cancer Research / Issue 1/2019
Electronic ISSN: 1756-9966
DOI: https://doi.org/10.1186/s13046-019-1431-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2019

EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo−/radioresistance in nasopharyngeal carcinoma

Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer

Low glucose and metformin-induced apoptosis of human ovarian cancer cells is connected to ASK1 via mitochondrial and endoplasmic reticulum stress-associated pathways

Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth

Combination of CTLA-4 and PD-1 blockers for treatment of cancer

PRIMA-1MET-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level

Keynote webinar | Spotlight on antibody–drug conjugates in cancer